mode百度云100as
百度云100as 时间:2021-01-04 阅读:()
58HongKongMedJVol16No1#Supplement1#February2010Beta1subunit–dependentmodulationofBKchannelbymembranecholesterolWWu,CPLau,HFTse,GRLiDepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThelargeconductanceCa2+-activatedK+(BKorMaxi-K)channelsareubiquitouslyexpressedindifferenttissueswithout(brain,liver,etc)orwith(smoothmuscleandheart)regulatorybeta-subunit,andplayanimportantroleinregulatingvariousphysiologicalprocessessuchascellexcitability,hormonesecretion,vascularactivity,etc.
RecentstudieshaveshownthatmembranecholesterolisamajorregulatorofseveralpotassiumchannelsincludingKirandKv1.
5channels.
However,theregulationofBKchannelsbycholesterolisnotfullyunderstood.
Methods:WholecellBKcurrentandBKsinglechannelcurrentwererecordedinwhole-cellpatchclampmodeandcell-attachedsinglechannelrecording,respectively,inHEK293cellsstablyexpressingMaxi-KgeneorMaxi-Kwithbeta1-subunit.
Results:Wefoundthatwhole-cellBKcurrentwassignificantlysuppressedwithcholesteroldepletionbymethyl-beta-cyclodextrin(MCD),whereascholesterol-saturated–MCDhadnoeffectonthecurrentamplitude.
SinglechannelrecordingshowedthatcholesteroldepletionsignificantlyreducedtheopenprobabilityofBKchannel,suggestingthatcholesteroldepletionlikelydecreasesthemembranechannelnumber.
Interestingly,incellsstablyexpressingSloandbeta1-subunit,depletionofmembranecholesterolincreasedBKcurrent,whilecholesterol-saturated–MCDreducedBKcurrent.
Conclusion:OurresultsdemonstratetheimportantevidencethatBKchannelsexhibitbeta1-subunit–dependentresponsestocholesterol.
TheenrichedcholesterolreducestheactivityofBKchannelsco-expressedwithMax-Kandbeta1-subunit,whichmayatleastinpartaccountsfortheoccurrenceofhypertensioninpatientswithhighplasmacholesterollevel,sincebeta-subunittranscriptsareabundantinvascularsmoothmuscle.
99PhaseI/IItrialofPTK787/ZK222584combinedwithintravenousdoxorubicinfortreatmentofpatientswithadvancedhepatocellularcarcinoma:implicationforanti-angiogenicapproachtohepatocellularcarcinomaTYau1,PChan1,KKNg2,STFan2,RTPoon21DepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKong2DepartmentofSurgery,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThisisaphaseI/IItrialaimingtoassesstheefficacyandtolerabilityofPTK787/ZK222584(PTK)incombinationwithintravenousdoxorubicinforthetreatmentofadvancedhepatocellularcarcinoma(HCC)patients.
Methods:InphaseI,advancedHCCpatientsreceivedPTKatescalatingdosestogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weekstoestablishthemaximumtolerateddose(MTD).
Subsequently,inphaseII,allpatientsreceivedthesameregimenwithoralPTKattheMTDdosetogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weeksforamaximumof6cycles.
Results:Ninepatientswererecruitedinphase1partwiththeMTDestablishedas750mgdaily.
Overall,27patientsreceivedtheregimenwithPTKat750mgdaily.
Themedianagewas52(range,23-73)yearsand63%ofpatientswerechronichepatitisBcarriers.
Notably,themajorityofpatientshadChildBcirrhosis.
Theoverallresponseratewas26.
0%withallpatientshavingpartialresponse,andanother20%ofpatientsachievedstablediseaseforatleast12weeks.
Themedianprogression-freesurvivalwas5.
4(0.
27-23.
6)monthsandoverallsurvivalwas7.
3(0.
8-23.
6)months.
Thecommonestgrade3or4non-haematologicaltoxicitiesweremucositis(11%)andalopecia(7%),respectively.
Grade3or4neutropeniawasobservedinseven(26%)patientswithtwohavingneutropenicsepsis.
Conclusion:ThecombinationofPTKwithintravenousdoxorubicinshowssynergisticactivityinadvancedHCCpatients.
Thus,theideaofcombininganti-angiogenicagenttogetherwithchemotherapymaywarrantfurtherevaluationinfutureclinicaltrialsofadvancedHCCpatients.
100
RecentstudieshaveshownthatmembranecholesterolisamajorregulatorofseveralpotassiumchannelsincludingKirandKv1.
5channels.
However,theregulationofBKchannelsbycholesterolisnotfullyunderstood.
Methods:WholecellBKcurrentandBKsinglechannelcurrentwererecordedinwhole-cellpatchclampmodeandcell-attachedsinglechannelrecording,respectively,inHEK293cellsstablyexpressingMaxi-KgeneorMaxi-Kwithbeta1-subunit.
Results:Wefoundthatwhole-cellBKcurrentwassignificantlysuppressedwithcholesteroldepletionbymethyl-beta-cyclodextrin(MCD),whereascholesterol-saturated–MCDhadnoeffectonthecurrentamplitude.
SinglechannelrecordingshowedthatcholesteroldepletionsignificantlyreducedtheopenprobabilityofBKchannel,suggestingthatcholesteroldepletionlikelydecreasesthemembranechannelnumber.
Interestingly,incellsstablyexpressingSloandbeta1-subunit,depletionofmembranecholesterolincreasedBKcurrent,whilecholesterol-saturated–MCDreducedBKcurrent.
Conclusion:OurresultsdemonstratetheimportantevidencethatBKchannelsexhibitbeta1-subunit–dependentresponsestocholesterol.
TheenrichedcholesterolreducestheactivityofBKchannelsco-expressedwithMax-Kandbeta1-subunit,whichmayatleastinpartaccountsfortheoccurrenceofhypertensioninpatientswithhighplasmacholesterollevel,sincebeta-subunittranscriptsareabundantinvascularsmoothmuscle.
99PhaseI/IItrialofPTK787/ZK222584combinedwithintravenousdoxorubicinfortreatmentofpatientswithadvancedhepatocellularcarcinoma:implicationforanti-angiogenicapproachtohepatocellularcarcinomaTYau1,PChan1,KKNg2,STFan2,RTPoon21DepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKong2DepartmentofSurgery,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThisisaphaseI/IItrialaimingtoassesstheefficacyandtolerabilityofPTK787/ZK222584(PTK)incombinationwithintravenousdoxorubicinforthetreatmentofadvancedhepatocellularcarcinoma(HCC)patients.
Methods:InphaseI,advancedHCCpatientsreceivedPTKatescalatingdosestogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weekstoestablishthemaximumtolerateddose(MTD).
Subsequently,inphaseII,allpatientsreceivedthesameregimenwithoralPTKattheMTDdosetogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weeksforamaximumof6cycles.
Results:Ninepatientswererecruitedinphase1partwiththeMTDestablishedas750mgdaily.
Overall,27patientsreceivedtheregimenwithPTKat750mgdaily.
Themedianagewas52(range,23-73)yearsand63%ofpatientswerechronichepatitisBcarriers.
Notably,themajorityofpatientshadChildBcirrhosis.
Theoverallresponseratewas26.
0%withallpatientshavingpartialresponse,andanother20%ofpatientsachievedstablediseaseforatleast12weeks.
Themedianprogression-freesurvivalwas5.
4(0.
27-23.
6)monthsandoverallsurvivalwas7.
3(0.
8-23.
6)months.
Thecommonestgrade3or4non-haematologicaltoxicitiesweremucositis(11%)andalopecia(7%),respectively.
Grade3or4neutropeniawasobservedinseven(26%)patientswithtwohavingneutropenicsepsis.
Conclusion:ThecombinationofPTKwithintravenousdoxorubicinshowssynergisticactivityinadvancedHCCpatients.
Thus,theideaofcombininganti-angiogenicagenttogetherwithchemotherapymaywarrantfurtherevaluationinfutureclinicaltrialsofadvancedHCCpatients.
100
incogne$2.5/月t芬兰VPS，AMD Ryzen、1Gbps带宽
IncogNet LLC是个由3个人运作的美国公司，主要特色是隐私保护，号称绝对保护用户的隐私安全。业务涵盖虚拟主机、VPS等，支持多种数字加密货币、PayPal付款。注册账号也很简单，输入一个姓名、一个邮箱、国家随便选，填写一个邮箱就搞定了，基本上不管资料的真假。当前促销的vps位于芬兰机房，全部都是AMD Ryzen系列的CPU，性能不会差的！5折优惠码：CRYPTOMONTH，支持：BTC,...
CloudCone：$14/年KVM-512MB/10GB/3TB/洛杉矶机房
CloudCone发布了2021年的闪售活动，提供了几款年付VPS套餐，基于KVM架构，采用Intel® Xeon® Silver 4214 or Xeon® E5s CPU及SSD硬盘组RAID10，最低每年14.02美元起，支持PayPal或者支付宝付款。这是一家成立于2017年的国外VPS主机商，提供VPS和独立服务器租用，数据中心为美国洛杉矶MC机房。下面列出几款年付套餐配置信息。CPU：...
热网互联33元/月,香港/日本/洛杉矶/韩国CN2高速线路云主机
热网互联怎么样?热网互联(hotiis)是随客云计算(Suike.Cloud)成立于2009年，增值电信业务经营许可证：B1-20203716)旗下平台。热网互联云主机是CN2高速回国线路，香港/日本/洛杉矶/韩国CN2高速线路云主机,最低33元/月;热网互联国内BGP高防服务器，香港服务器，日本服务器全线活动中，大量七五折来袭!点击进入：热网互联官方网站地址热网互联香港/日本/洛杉矶/韩国cn2...
百度云100as为你推荐
-
虚拟空间主机有了虚拟主机和空间怎么用域名价格什么是域名的商业价值？？国外空间租用租用美国空间网站服务器租用哪些网站适合独立服务器租用？价格方面怎么样？国内ip代理谁有最快的国内IP代理HTTP免费vps服务器免费VPS服务器。和免费的好用虚拟主机域名购买域名注册和购买是一个意思吗？域名购买为什么要购买域名，域名是干嘛用的?台湾vps台湾服务器租用托管那里好台湾vps哪个地区的VPS从大陆访问快呢。